ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Descrizione completa

Dettagli Bibliografici
Autore principale: R.T. Saygitov
Natura: Articolo
Lingua:English
Pubblicazione: "Paediatrician" Publishers LLC 2008-08-01
Serie:Вопросы современной педиатрии
Accesso online:https://vsp.spr-journal.ru/jour/article/view/1441

Documenti analoghi